AU2005249187B2 - Oral form of administration containing probiotic bacteria - Google Patents

Oral form of administration containing probiotic bacteria Download PDF

Info

Publication number
AU2005249187B2
AU2005249187B2 AU2005249187A AU2005249187A AU2005249187B2 AU 2005249187 B2 AU2005249187 B2 AU 2005249187B2 AU 2005249187 A AU2005249187 A AU 2005249187A AU 2005249187 A AU2005249187 A AU 2005249187A AU 2005249187 B2 AU2005249187 B2 AU 2005249187B2
Authority
AU
Australia
Prior art keywords
oral administration
administration form
form according
coating
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2005249187A
Other languages
English (en)
Other versions
AU2005249187A1 (en
Inventor
Stefan Henke
Iris Manneck
Markus Rudolph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34980007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005249187(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU2005249187A1 publication Critical patent/AU2005249187A1/en
Application granted granted Critical
Publication of AU2005249187B2 publication Critical patent/AU2005249187B2/en
Assigned to THE PROCTER & GAMBLE COMPANY reassignment THE PROCTER & GAMBLE COMPANY Request for Assignment Assignors: MERCK PATENT GMBH
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2005249187A 2004-05-28 2005-05-04 Oral form of administration containing probiotic bacteria Expired AU2005249187B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004026706.5 2004-05-28
DE102004026706A DE102004026706A1 (de) 2004-05-28 2004-05-28 Orale Darreichungsform enthaltend probiotische Bakterien
PCT/EP2005/004835 WO2005117921A1 (de) 2004-05-28 2005-05-04 Orale darreichungsform enthaltend probiotische bakterien

Publications (2)

Publication Number Publication Date
AU2005249187A1 AU2005249187A1 (en) 2005-12-15
AU2005249187B2 true AU2005249187B2 (en) 2011-03-17

Family

ID=34980007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005249187A Expired AU2005249187B2 (en) 2004-05-28 2005-05-04 Oral form of administration containing probiotic bacteria

Country Status (20)

Country Link
US (2) US20090162322A1 (cg-RX-API-DMAC10.html)
EP (1) EP1753440B1 (cg-RX-API-DMAC10.html)
JP (1) JP5070043B2 (cg-RX-API-DMAC10.html)
KR (1) KR101289413B1 (cg-RX-API-DMAC10.html)
CN (1) CN1956724B (cg-RX-API-DMAC10.html)
AT (1) ATE386534T1 (cg-RX-API-DMAC10.html)
AU (1) AU2005249187B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0511615B8 (cg-RX-API-DMAC10.html)
CA (1) CA2568171C (cg-RX-API-DMAC10.html)
CY (1) CY1107399T1 (cg-RX-API-DMAC10.html)
DE (2) DE102004026706A1 (cg-RX-API-DMAC10.html)
DK (1) DK1753440T3 (cg-RX-API-DMAC10.html)
ES (1) ES2299034T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA06013686A (cg-RX-API-DMAC10.html)
PL (1) PL1753440T3 (cg-RX-API-DMAC10.html)
PT (1) PT1753440E (cg-RX-API-DMAC10.html)
RU (1) RU2376023C2 (cg-RX-API-DMAC10.html)
SI (1) SI1753440T1 (cg-RX-API-DMAC10.html)
WO (1) WO2005117921A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200610768B (cg-RX-API-DMAC10.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1885207B1 (en) * 2005-05-18 2011-07-06 DSM IP Assets B.V. Compositions for enteral application of microorganisms
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
DK2068899T3 (da) * 2006-10-02 2015-09-28 Dupont Nutrition Biosci Aps Lactobacillus acidophilus til anvendelse til reducering af forekomsten og varigheden af luftvejsinfektioner
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
EP2464721B1 (en) 2009-08-14 2015-10-21 DuPont Nutrition Biosciences ApS Coated dehydrated microorganisms with enhanced stability and viability
WO2011111783A1 (ja) 2010-03-12 2011-09-15 カルピス株式会社 大腸におけるビフィズス菌の増加及び減少抑制剤
US9585922B2 (en) 2011-05-06 2017-03-07 Organobalance Medical Ag Lactic acid bacteria that co-aggregate with pathogenic bacteria
US9308227B2 (en) 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
RU2491079C1 (ru) * 2012-07-13 2013-08-27 Федеральное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Комплексный пробиотический препарат и способ его получения
TWI481409B (zh) * 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
US10849940B2 (en) * 2013-06-10 2020-12-01 Brock M. Lundberg Prebiotics of highly refined cellulose
KR101470995B1 (ko) * 2013-08-30 2014-12-09 주식회사 바이오리쏘스 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물
EP3164145A4 (en) 2014-07-01 2018-01-17 Probi Usa, Inc. Bi-layer dual release probiotic tablets
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
US10339273B2 (en) 2015-11-18 2019-07-02 Warsaw Orthopedic, Inc. Systems and methods for pre-operative procedure determination and outcome predicting
CN111870617B (zh) * 2019-11-04 2022-06-10 深圳碳云智能数字生命健康管理有限公司 肠道益生菌补剂配方的确定方法、装置、存储介质及处理器
CN111110703B (zh) * 2020-01-13 2020-12-01 华中农业大学 动物双歧杆菌及其制备的复合菌制剂在制备治疗或预防禽流感病毒感染的药物中的应用
KR102769334B1 (ko) * 2021-10-20 2025-02-14 경희대학교 산학협력단 대변 미생물총을 포함하는 가축 증체용 조성물
CN114917259B (zh) * 2022-02-15 2023-10-13 中国科学院上海硅酸盐研究所 一种二维氢硅烯-微生物复合材料及其制备方法和应用
TWI857740B (zh) * 2023-08-09 2024-10-01 統一企業股份有限公司 複合益生菌粉及其用途以及益生菌組合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627173A1 (en) * 1993-05-31 1994-12-07 GIULIANI S.p.A. Preparation for dietetic use or as a food supplement, with targeted release in the colon
AU770792B2 (en) * 1999-08-12 2004-03-04 Merck Patent Gmbh Oral form of administration containing probiotic micro-organisms

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58157726A (ja) * 1982-03-11 1983-09-19 Shin Etsu Chem Co Ltd 固形薬剤用腸溶性コ−テイング剤組成物
JPH024016A (ja) * 1988-06-20 1990-01-09 Fujitsu Ltd 半導体集積回路
JPH0441434A (ja) * 1990-06-07 1992-02-12 Asahi Breweries Ltd 腸溶性コーティングを施した乳酸菌錠剤
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
CN1156271C (zh) * 2000-04-29 2004-07-07 中国科学技术大学 一种固体药剂用高分子包衣粉及其制备方法
RU2171672C1 (ru) * 2000-08-31 2001-08-10 Московская медицинская академия им. И.М. Сеченова Способ получения микрокапсулированных форм лактобактерий
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US20020160048A1 (en) * 2001-02-15 2002-10-31 Karoline Bechtold-Peters Medical formulation containing a muscarinic agonist
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627173A1 (en) * 1993-05-31 1994-12-07 GIULIANI S.p.A. Preparation for dietetic use or as a food supplement, with targeted release in the colon
AU770792B2 (en) * 1999-08-12 2004-03-04 Merck Patent Gmbh Oral form of administration containing probiotic micro-organisms

Also Published As

Publication number Publication date
CY1107399T1 (el) 2012-12-19
US20190110997A1 (en) 2019-04-18
BRPI0511615B1 (pt) 2018-01-23
PL1753440T3 (pl) 2008-05-30
RU2006145056A (ru) 2008-07-10
BRPI0511615B8 (pt) 2021-05-25
BRPI0511615A (pt) 2008-01-02
JP5070043B2 (ja) 2012-11-07
AU2005249187A1 (en) 2005-12-15
ATE386534T1 (de) 2008-03-15
DK1753440T3 (da) 2008-06-02
EP1753440B1 (de) 2008-02-20
ZA200610768B (en) 2008-07-30
ES2299034T3 (es) 2008-05-16
SI1753440T1 (sl) 2008-08-31
CA2568171A1 (en) 2005-12-15
MXPA06013686A (es) 2007-02-13
CN1956724B (zh) 2013-08-28
CN1956724A (zh) 2007-05-02
KR20070024539A (ko) 2007-03-02
EP1753440A1 (de) 2007-02-21
RU2376023C2 (ru) 2009-12-20
KR101289413B1 (ko) 2013-08-07
CA2568171C (en) 2013-09-17
DE102004026706A1 (de) 2005-12-15
US20090162322A1 (en) 2009-06-25
PT1753440E (pt) 2008-05-28
WO2005117921A1 (de) 2005-12-15
JP2008500294A (ja) 2008-01-10
DE502005002929D1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
US20190110997A1 (en) Oral administration form comprising probiotic bacteria
AU770792B2 (en) Oral form of administration containing probiotic micro-organisms
US11103542B2 (en) Composition and method for maintaining healthy kidney function
JPH0441434A (ja) 腸溶性コーティングを施した乳酸菌錠剤
AU2006296797B2 (en) Method for stabilising pharmaceutical administration forms that contain micro-organisms
KR102483912B1 (ko) 연질캡슐형 건강기능식품의 제조방법
US6451344B1 (en) Sugar coated tablets
JP5940869B2 (ja) 腸内環境改善有核錠製剤及びハードカプセル製剤
WO2018125735A1 (en) Composition and method for maintaining healthy kidney function
KR102163637B1 (ko) 건강기능식품의 제조방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: THE PROCTER & GAMBLE COMPANY

Free format text: FORMER OWNER(S): MERCK PATENT GMBH

MK14 Patent ceased section 143(a) (annual fees not paid) or expired